GSK plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 01:02PM BST. Market open.
| Previous Close | 1,673.00 |
| Open | 1,685.50 |
| Bid | 1,711.50 x 0 |
| Ask | 1,712.50 x 0 |
| Day's Range | 1,673.00 - 1,714.50 |
| 52 Week Range | 1,302.60 - 1,725.81 |
| Volume | |
| Avg. Volume | 8,394,194 |
| Market Cap | 69.953B |
| Beta (5Y Monthly) | 0.27 |
| PE Ratio (TTM) | 14.27 |
| EPS (TTM) | 1.20 |
| Earnings Date | May 01, 2024 |
| Forward Dividend & Yield | 0.64 (3.83%) |
| Ex-Dividend Date | Feb 22, 2024 |
| 1y Target Est | N/A |
Evening StandardFTSE 100 Live 1 May: Index flat before US Fed interest rates call, Aston Martin falls, BT among top risers
Upgraded profit guidance by GSK stood out today in a session featuring updates by Next, Smith & Nephew and Sensodyne business Haleon. The quartet all signalled robust trading at the start of 2024, helping the FTSE 100 index to begin May in resilient fashion. Traders are also looking ahead to tonight’s US Federal Reserve decision and whether September is still the most likely month for the first cut.
PA Media: MoneyGSK raises profit guidance as vaccine demand grows
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
ZacksGSK (GSK) Q1 Earnings and Revenues Surpass Estimates
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.